When COVID-19 Meets Interstitial Lung Disease: Implications for Acute and Long-Term Management
Faculty:
Lisa H. Lancaster, MD
Professor of Medicine
Vanderbilt University Medical Center
Nashville, TN
Steven Nathan, MD
Medical Director, Advanced Lung Disease & Transplant Program
Inova Fairfax Hospital
Falls Church, VA USA
Professor of Medicine
Virginia Commonwealth University - Inova Fairfax Campus
Description:
After completing this activity, the participant should be better able to:
- Discuss the impact of COVID-19 in patients with PF-ILDs
- Interpret the evidence for the management of patients with PF-ILDs who have contracted COVID-19
- Review the long-term management and follow-up of patients with PF-ILDs post-COVID-19
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and TME. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity is supported by an educational grant from Boehringer-Ingelheim